COLOPLAST A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 850 DKK | +1.07% |
|
+0.57% | +10.10% |
| May. 15 | COLOPLAST : Multiple silver linings in spite of a soft Q2 24 |  |
| May. 07 | European shares hit one-month high as earnings take centre stage | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 27.04B 3.94B | Sales 2025 * | 29.41B 4.28B | Capitalization | 191B 27.84B |
|---|---|---|---|---|---|
| Net income 2024 * | 5.24B 764M | Net income 2025 * | 6.12B 891M | EV / Sales 2024 * | 7.79 x |
| Net Debt 2024 * | 19.4B 2.83B | Net Debt 2025 * | 17.9B 2.61B | EV / Sales 2025 * | 7.11 x |
| P/E ratio 2024 * |
36.6
x | P/E ratio 2025 * |
31.3
x | Employees | 15,930 |
| Yield 2024 * |
2.39% | Yield 2025 * |
2.59% | Free-Float | 58.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on Coloplast A/S
More press releases
| 1 day | +1.07% | ||
| 1 week | +0.57% | ||
| Current month | +0.43% | ||
| 1 month | -5.16% | ||
| 3 months | -4.92% | ||
| 6 months | +14.03% | ||
| Current year | +10.10% |
1 week
826.60
856.40
1 month
804.00929.20
Current year
757.80977.60
1 year
689.20977.60
3 years
689.201 194.00
5 years
689.201 194.00
10 years
413.101 194.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 07-12-31 | |
| Director of Finance/CFO | 52 | 05-12-31 | |
| Chairman | 65 | 87-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 76 | 68-09-30 | |
Carsten Hellmann
BRD | Director/Board Member | 60 | 17-11-30 |
| Chairman | 65 | 87-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.81% | 200 M€ | +17.40% | ||
| 1.11% | 253 M€ | +7.93% | ||
| 0.96% | 48 M€ | +9.95% | ||
| 0.85% | 3 M€ | +9.95% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 850 | +1.07% | 245,570 |
| 24-05-16 | 841 | +0.43% | 162,677 |
| 24-05-15 | 837.4 | +0.29% | 262,715 |
| 24-05-14 | 835 | -1.07% | 250,501 |
Delayed Quote Nasdaq Copenhagen, May 17, 2024 at 10:59 am EDT
More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
2024-06-06
- Investor Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
850
DKK
Average target price
912.3
DKK
Spread / Average Target
+7.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +10.10% | 27.85B | |
| -30.75% | 3.09B | |
| +35.19% | 2.66B | |
| -18.85% | 2.44B | |
| +6.85% | 2.24B | |
| +33.33% | 2.05B | |
| -4.71% | 2.02B | |
| +34.05% | 1.35B | |
| +3.25% | 1.33B | |
| +21.43% | 1.29B |
- Stock Market
- Equities
- COLO B Stock
